Project Farma Partners with Valkit.ai to Modernize Digital Validation with AI

As AI continues to reshape digital validation across life sciences manufacturing, organizations are looking for modern, data-driven approaches to commissioning, qualification, and validation activities that can improve visibility, streamline execution, and reduce manual burden while maintaining compliance.

To help support this industry shift, Project Farma has partnered with Valkit.ai, expanding its digital validation AI capabilities for pharmaceutical and biotech manufacturers. Valkit.ai develops digital validation technologies designed to support life sciences applications through modern, data-driven approaches to validation and compliance activities.

By combining Project Farma’s deep validation and manufacturing expertise with Valkit.ai’s AI-driven platform, this partnership strengthens our ability to help clients streamline execution, improve traceability, reduce documentation burden, and accelerate the path to delivering therapies to patients.

For clients, that means fewer delays and greater confidence in their validation programs. For patients, it means faster access to life-changing therapies.

As digital validation AI tools become increasingly relevant across regulated manufacturing environments, Project Farma is committed to expanding its technology partnerships to ensure our clients have access to the most modern and effective approaches available. This partnership with Valkit.ai represents an important step in that direction, delivering a trusted and streamlined approach that supports faster project execution while maintaining the high standards required in regulated manufacturing environments.

Click Here to read the full announcement on the PerkinElmer newsroom for additional details on the partnership and its significance for the future of digital validation in life sciences.